Don't be afraid to give up the good to go for the great.
Every weekday, we hand you a mad startup idea! What you do with it is up to you.
✅ 4 sections ⏱️ 4 minutes 🚫 No fluff.
💡 Mad Idea • 📈 Mad Trends • 🛠 Mad Hack • 📰 Mad News
Mad Idea of the Day
CLINIC CART
8 LAKH INDIAN CLINICS BUY MEDICINES, GLOVES, AND SYRINGES AT MRP. THE HOSPITAL NEXT DOOR PAYS 40% LESS.
The Challenge: India has 8 lakh independent clinics and nursing homes — run by solo doctors, small practitioner groups, and rural health centres. They buy medicines, surgical consumables, diagnostic kits, and equipment from local medical distributors at or near MRP. Large hospital chains like Apollo and Fortis negotiate 35–50% discounts through bulk procurement. The independent clinic gets no such deal. There is no aggregation layer, no collective bargaining, no B2B procurement platform built for the small clinic. Is India's ₹4.5 lakh crore pharma market really going to ignore 8 lakh buyers?
The Solution: Clinic Cart — the procurement marketplace for independent healthcare providers 💊.
An app where clinics browse, compare, and order medicines, gloves, consumables, diagnostic kits, and equipment from verified distributors — with group-buying pricing that kicks in when 10+ clinics in a geography order together. Onboarding: doctor uploads MCI registration in 5 minutes. Week 1 price comparison versus what they pay today. The wedge is the savings shock — when a clinic sees it's paying ₹18/saline bag versus the ClinicCart price of ₹10.50, they never go back to the local distributor. Practo manages appointments. We manage the supply chain underneath.
Business Model:
4% take rate on GMV (vs. pharma distributor margins of 8–12%)
₹999/month SaaS for inventory management, expiry tracking, and reorder alerts
₹199 per group-buy event: clinics pay to join a coordinated bulk order
Exit Strategy: 1 lakh clinics on-platform by FY30, ₹3,000 Cr annual GMV, ₹120 Cr revenue. Acquirers: PharmEasy parent API Holdings, Tata 1mg, or any hospital chain building a supplier network play.
Mad Trends
India's digital lending startups are all sprinting toward the same door: Dalal Street.
The Shift: After years of being labelled "high-risk fintech," India's digital lending sector is entering a new phase — profitable, regulated, and IPO-ready.
The Trend: Kissht crossed ₹600 Cr revenue in Q4 FY26 with profit up 52% year-on-year. KreditBee raised $280 Mn in April 2026 at a $1.5 Bn valuation — joining the unicorn club and preparing for a public listing. Moneyview and Fibe are also filing. India's digital lending sector crossed ₹5 lakh Cr in disbursals in FY26, with the NBFC and fintech overlap tightening under RBI supervision.
The Drivers:
Workforce: 12 crore Indians now have an active digital loan account, up from 4 crore in FY22
Market Size: India's consumer digital lending market estimated at ₹12 lakh Cr by FY29
Concentration: Kissht, KreditBee, Fibe, and Moneyview collectively hold 38% of unsecured digital lending volume
🔥 Four digital lenders going public in the same 18-month window means one thing: the risk-reward math finally works. The question is who survives the rate cycle after listing.
Mad Hack
The Wrong Start: Madhusudan E launched KreditBee in 2018 to give personal loans to salaried workers earning ₹15,000–₹25,000 a month. Every bank in India already rejected these customers as too risky, too thin on credit history, and too small-ticket to bother with. NBFCs charged 36–48% interest and buried them in paperwork. The founding team had no legacy NBFC infrastructure, no branch network, and no bureau data to underwrite on.
The Pivot: Madhusudan built an alternative underwriting model using mobile behavior, employment verification, and GST compliance patterns instead of traditional CIBIL scores. He went deeper into tier-2 cities where credit demand was highest and competition was lowest. He kept ticket sizes small — ₹40,000 average — and focused on repayment experience, not just disbursals.
The Payoff: In April 2026, KreditBee raised ₹2,595 Cr ($280 Mn) at whopping $1.5 Bn valuation, becoming India's 128th unicorn. The platform has disbursed 6 cr loans to 1.8 cr unique customers. The IPO is on the way.
🎯 The Builder Lesson: The customers banks ignore are your entire addressable market — if your underwriting is smarter than theirs.
Mad News Today
🏥 Nobel Hygiene converts to public company ahead of planned ₹2,500 Cr IPO — Diapers and hygiene going to Dalal Street.
💊 Kissht crosses ₹619 Cr revenue in Q4 FY26; profit jumps 52% — stock now 56% above issue price — Digital lending's profitability proof point.
✈️ EaseMyTrip posts ₹152 Cr revenue in Q4 FY26; slips into ₹15 Cr loss as service costs triple — Travel tech still finding its floor.
🧴 Nykaa crosses ₹1 Bn revenue mark in FY26 as profit surges — first Indian beauty platform to hit the milestone — D2C beauty's landmark year.